< Back to scientific publications

Magazine 14.17

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First ItalianζoRk STudy (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.

Date: 2021

Scope of interest: Epilepsy




You may also be interested in:

Magazine 17,152

Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-Term Care Facilities: Data From the GeroCovid VAX Study.

Authors: Virgilio E, Trevisan C, Abbatecola A, Malara A, Palmieri A, Fedele G, Stefanelli P, Leone P, Schiavoni I, Maggi S, Volpato S, Antonelli Incalzi R, Onder G; GeroCovid Vax Working Group; GeroCovid Vax Working Group.

Date: 2022

Scope of interest: diabetes


Read details
Report/Poster of Convention/Congress Act

Study session on the medicine of migration Infectious diseases ; Case study on the transdisciplinary setting.

Authors: ilaria uccella

Date: 2012

Scope of interest: infectious disease training programs


Read details
Magazine 12.56

Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.

Authors: Fisicaro F, Di Napoli M, Liberto A, Fanella M, Di Stasio F, Pennisi M, Bella R, Lanza G, Mansueto G.

Date: 2021

Scope of interest: COVID-19 and neurological sequelae


Read details